Modeling studies on the role of vitamins B1 (thiamin), B3 (nicotinamide), B6 (pyridoxamine), and caffeine as potential leads for the drug design against COVID-19.

Aghamohammadi, Mohammad; Sirouspour, Mehdi; Goncalves, Arlan S; França, Tanos Celmar Costa; LaPlante, Steven R; Shahdousti, Parvin

Aghamohammadi, Mohammad; Sirouspour, Mehdi; Goncalves, Arlan S; França, Tanos Celmar Costa; LaPlante, Steven R; Shahdousti, Parvin.

Afiliación

Aghamohammadi M; Department of Chemistry, Borujerd Branch, Islamic Azad University, Borujerd, Iran. aghamo_m@yahoo.com.
Sirouspour M; Independent Researcher, Montreal, QC, Canada.
Goncalves AS; Department of Chemistry, Federal Institute of Espirito Santo, Vila Velha, ES, Brazil.
França TCC; Graduate Program in Chemistry, Federal University of Espirito Santo, Vitoria, ES, Brazil.
LaPlante SR; Université de Québec, INRS - Centre Armand-Frappier Santé Biotechnologie, 531 Boulevard Des Prairies, Laval, Québec, H7V 1B7, Canada.
Shahdousti P; Laboratory of Molecular Modeling Applied to the Chemical and Biological Defense (LMCBD), Military Institute of Engineering, Rio de Janeiro, RJ, Brazil.

J Mol Model ; 28(12): 380, 2022 Nov 07.

Article en En | MEDLINE | ID: mdl-36342543

Asunto(s)

Tratamiento Farmacológico de COVID-19; Humanos; SARS-CoV-2; Piridoxamina; Tiamina/metabolismo; Pandemias; Cafeína/farmacología; Niacinamida; Simulación del Acoplamiento Molecular; Antivirales/farmacología; Antivirales/química; Diseño de Fármacos; Vitaminas

Palabras clave

COVID-19; Caffeine; Docking; Molecular dynamic simulations; Vitamin B

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Mol Model Asunto de la revista: BIOLOGIA MOLECULAR Año: 2022 Tipo del documento: Article País de afiliación: Irán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google